Substantial Transformation

Today, in Acetris Health, LLC v. United States, the Federal Circuit held that a pharmaceutical manufactured in the United States qualified for sale, under the Trade Agreements Act of 1979 (TAA), to the Department of Veterans Affairs even though the active pharmaceutical ingredient (API) came from a non-designated country, India.

In reaching this decision,